No insider purchase over the last 90 days. The latest was filed 02 Apr 2021.
Coloplast A/S, founded in 1957, is a Health Care company based in Humlebæk, Denmark. Its directors and officers file their transactions with Finanstilsynet DK. Between 18 October 2025 and 18 October 2026, 3 insiders published 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 7 filings in twelve months, the company is more active than the median of 4 filings across the 74 companies we follow on the same exchange. Our records for Coloplast A/S go back to 2005, with 13 purchases and 3 sales on the open market in total.
No insider has bought Coloplast A/S shares on the open market in the past twelve months. Half of the filings or more reach the Finanstilsynet DK feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 221 declarations
Coloplast A/S is a Danish company that develops medical products for wound care, incontinence, and urological care. It is listed on the Copenhagen Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Humlebæk, Denmark · Founded: 1957 · 14,685 employees (2022) · Wikipedia article
Source: Wikidata (CC0).